EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 07 listopada 2024. Database contains 4821 unique substances/entries.
Filter the list
|
293-767-8
|
91082-53-0
|
Carc. 1B; Muta. 1B |
|||
|
271-020-7
|
68513-87-1
|
Carc. 1B; Muta. 1B |
|||
|
The distillate from high temperature coal tar having an approximate distillation range of 130°C to 250°C (266°F to 410°F). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.
|
266-016-7
|
65996-82-9
|
Carc. 1B; Muta. 1B |
||
|
Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.
|
295-535-1
|
92062-20-9
|
Carc. 1B |
||
|
The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700°C (1292°F)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal- and coke-type materials.
|
273-615-7
|
68990-61-4
|
Carc. 1B |
||
|
The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700°C (1292°F)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.
|
266-024-0
|
65996-89-6
|
Carc. 1A |
||
|
The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700°C (1292°F)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.
|
266-025-6
|
65996-90-9
|
Carc. 1A |
||
|
The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.
|
293-764-1
|
91082-50-7
|
Carc. 1B |
||
|
The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydrocarbons, phenolic compounds, nitrogen bases and thiophene.
|
232-361-7
|
8007-45-2
|
Carc. 1A |
||
|
200-927-2
|
76-03-9
|
Skin Corr. 1A |
|||
|
211-479-2
|
650-51-1
|
STOT SE 3 |
|||
|
251-793-7
|
34014-18-1
|
Acute Tox. 4 |
|||
|
204-178-2
|
117-18-0
|
Acute Tox. 4; Skin Sens. 1 |
|||
|
203-495-3
|
107-49-3
|
Acute Tox. 1; Acute Tox. 2 |
|||
|
235-963-8
|
13071-79-9
|
Acute Tox. 1; Acute Tox. 2 |
|||
|
251-637-8
|
33693-04-8
|
Acute Tox. 4 |
|||
|
227-637-9
|
5915-41-3
|
Acute Tox. 4; STOT RE 2 |
|||
|
262-967-7
|
61788-32-7
|
yes |
|||
|
262-967-7
|
61788-32-7
|
yes |
|||
|
208-760-7
|
540-88-5
|
Flam. Liq. 2 |
|||
|
216-768-7
|
1663-39-4
|
Flam. Liq. 2; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
|||
|
212-105-0
|
762-75-4
|
Flam. Liq. 2; Eye Irrit. 2; STOT SE 3 |
|||
|
200-915-7
|
75-91-2
|
Muta. 2 |
|||
|
216-653-1
|
1634-04-4
|
Flam. Liq. 2; Skin Irrit. 2 |
|||
|
208-757-0
|
540-80-7
|
Flam. Liq. 2; Acute Tox. 4 |
|||
|
222-389-8
|
3457-61-2
|
Org. Perox. E; Skin Irrit. 2 |
|||
|
235-541-3
|
12267-73-1
|
Repr. 1B |
yes |
||
|
236-669-2
|
13463-39-3
|
Flam. Liq. 2; Carc. 2; Repr. 1B; Acute Tox. 2 |
|||
|
204-274-4
|
118-75-2
|
Eye Irrit. 2; Skin Irrit. 2 |
|||
|
204-825-9
|
127-18-4
|
Carc. 2 |
|||
|
204-171-4
|
117-08-8
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
215-582-3
|
1333-22-8
|
Acute Tox. 4 |
|||
|
215-910-5
|
1449-55-4
|
Acute Tox. 4 |
|||
|
201-083-8
|
78-10-4
|
Flam. Liq. 3; Acute Tox. 4; Eye Irrit. 2; STOT SE 3 |
|||
|
201-075-4
|
78-00-2
|
yes |
|||
|
204-126-9
|
116-14-3
|
Carc. 1B |
|||
|
230-625-6
|
7226-23-5
|
Repr. 2; Acute Tox. 4; Eye Dam. 1 |
|||
|
202-625-6
|
97-99-4
|
Repr. 1B; Eye Irrit. 2 |
|||
|
251-823-9
|
34090-76-1
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
203-726-8
|
109-99-9
|
Flam. Liq. 2; Carc. 2; Eye Irrit. 2; STOT SE 3 |
|||
|
203-239-0
|
104-80-3
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
|||
|
234-290-7
|
11070-44-3
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
247-570-9
|
26266-63-7
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
203-728-9
|
110-01-0
|
Flam. Liq. 2; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
|||
|
204-783-1
|
126-33-0
|
Acute Tox. 4 |
|||
|
235-380-9
|
12202-17-4
|
yes |
|||
|
231-711-6
|
7696-12-0
|
Carc. 2; Acute Tox. 4; STOT SE 2 |
|||
|
213-979-6
|
1070-70-8
|
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1 |
|||
|
202-605-7
|
97-74-5
|
Acute Tox. 4; Skin Sens. 1 |
|||
|
215-245-0
|
1314-85-8
|
Flam. Sol. 2; Water-react. 1; Acute Tox. 4 |
|||